data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Genprex
(NASDAQ:GNPX)
1.50
0.01[0.67%]
At close: May 27
1.49
-0.0100[-0.67%]
After Hours: 5:17PM EDT
Day High/Low1.47 - 1.53
52 Week High/Low1.17 - 4.07
Open / Close1.47 / 1.5
Float / Outstanding47.3M / 47.9M
Vol / Avg.115.7K / 254K
Mkt Cap71.8M
P/E-
50d Avg. Price1.83
Div / Yield-
Payout Ratio-
EPS-0.12
Total Float47.3M

Genprex (NASDAQ:GNPX), Quotes and News Summary

Genprex (NASDAQ: GNPX)

Day High/Low1.47 - 1.53
52 Week High/Low1.17 - 4.07
Open / Close1.47 / 1.5
Float / Outstanding47.3M / 47.9M
Vol / Avg.115.7K / 254K
Mkt Cap71.8M
P/E-
50d Avg. Price1.83
Div / Yield-
Payout Ratio-
EPS-0.12
Total Float47.3M
Benzinga - Mar 31, 2022, 7:21AM
Benzinga - Mar 2, 2022, 8:05AM
Benzinga - Jan 27, 2022, 11:26AM
Benzinga - Jan 12, 2022, 3:33PM
Benzinga - Jan 10, 2022, 9:24AM
Benzinga - Jan 5, 2022, 10:55AM
Benzinga - Jan 4, 2022, 8:05AM
Benzinga - Jan 3, 2022, 10:43AM
Benzinga - Jan 3, 2022, 9:21AM
Benzinga - Jan 3, 2022, 9:00AM
Benzinga - Jan 3, 2022, 8:02AM
Benzinga - Sponsored
Benzinga - Jun 23, 2021, 12:20PM
Benzinga - Jun 23, 2021, 8:30AM
load more
Sector: Health Care.Industry: Biotechnology
Genprex Inc is a clinical-stage gene therapy company. It is focused on developing life-changing therapies for patients with cancer and diabetes. Genprex's technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who have limited treatment options. It works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies to provide novel treatment approaches for patients with cancer and diabetes.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-12
REV
Q1 2022Est.ActualSurprise
EPS-0.120
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Genprex Questions & Answers

Q
How do I buy Genprex (GNPX) stock?
A

You can purchase shares of Genprex (NASDAQ: GNPX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Genprex's (GNPX) competitors?
Q
What is the target price for Genprex (GNPX) stock?
A

The latest price target for Genprex (NASDAQ: GNPX) was reported by Maxim Group on Friday, September 14, 2018. The analyst firm set a price target for 5.00 expecting GNPX to rise to within 12 months (a possible 233.33% upside). 0 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Genprex (GNPX)?
A

The stock price for Genprex (NASDAQ: GNPX) is $1.5 last updated May 27, 2022, 8:00 PM UTC.

Q
Does Genprex (GNPX) pay a dividend?
A

There are no upcoming dividends for Genprex.

Q
When is Genprex (NASDAQ:GNPX) reporting earnings?
A

Genprex’s Q2 earnings are confirmed for Friday, August 12, 2022.

Q
Is Genprex (GNPX) going to split?
A

There is no upcoming split for Genprex.

Q
What sector and industry does Genprex (GNPX) operate in?
A

Genprex is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.